Is the benign breast disease breast cancer model well calibrated?

Journal of Clinical Oncology

Volumn 33, Issue 25, 2015, Pages 2829-2830

  Gail, Mitchell H ^a   Pfeiffer, Ruth M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; FOLLOW UP; HUMAN; LETTER; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; BIOPSY; BREAST NEOPLASMS; FEMALE; PROCEDURES; RISK ASSESSMENT;

BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; RISK ASSESSMENT;

EID: 84941352758     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.6177     Document Type: Letter

References (6)

1. Pankratz VS, Degnim AC, Frank R.D., et al: Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol 33:923-929, 2015
2. Mealiffe ME, Stokowski RP, Rhees B.K., et al: Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 102:1618-1627, 2010
3. Gail MH, Pfeiffer RM: On criteria for evaluating models of absolute risk. Biostatistics 6:227-239, 2005
4. Cornfield J: A method of estimating comparative rates from clinical data: Applications to cancer of the lung, breast and cervix. J Natl Cancer Inst 11:1269-1275, 1951
5. Mantel N: Synthetic retrospective studies and related topics. Biometrics 29:479-486, 1973
6. Prentice RL, Pyke R: Logistic disease incidence models and case-control studies. Biometrika 66:403-411, 1979